Advertisement

Topics

Bristol-Myers Squibb and Pfizer to Present New Analyses of Eliquis™ (apixaban) Clinical and Real-World Data at the American College of Cardiology 2017 Scientific Session

08:30 EST 6 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Post-hoc Analyses from the ARISTOTLE Trial Featured in Late-Breaker and Poster Sessions Real-World Data Analyses Include Database Reviews of U.S. Medicare Patient Population Bristol-...

Other Sources for this Article

Bristol-Myers Squibb
Media:
Rob Perry, 407-492-4616
rob.perry@bms.com
or
Investors:
Timothy Power, 609-252-7509
timothy.power@bms.com
or
Pfizer Inc.
Media:
Steven Danehy, 212-733-1538
steven.danehy@pfizer.com
or
Investors:
Ryan Crowe, 212-733-8160
ryan.crowe@pfizer.com

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb and Pfizer to Present New Analyses of Eliquis™ (apixaban) Clinical and Real-World Data at the American College of Cardiology 2017 Scientific Session"

Advertisement
Quick Search
Advertisement
Advertisement